Andere talen NexgenRx Inc.

Aandelen

NXG

CA65337X1042

Beurs gesloten - Toronto S.E. Andere beurzen 21:11:09 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,22 ^CAD	-.--%		-.--%	-.--%

05/04	NexgenRx Inc. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
2023	NEXGENRX INC. kondigt aan dat Dave Bennett zich terugtrekt uit de Raad van Bestuur	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	05/04
NEXGENRX INC. Announces the Retirement of Dave Bennett from its Board of Directors	29/12
NEXGENRX Inc Announces Declaration of Dividend, Payable on or Before January 4, 2024	20/12
NexgenRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23/11
NexgenRx Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	21-08-23
NexgenRx Inc. Announces Declaration of Dividend in Respect of All of Its Outstanding Common Shares , Payable on or Before June 30, 2023	15-06-23
NexgenRx's Q1 Profit Falls, Revenue Rises	19-05-23
NexgenRx Inc. Appoints Dave Bennett as New Director	19-05-23
NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	19-05-23
NexgenRx Swings to Loss in Q4	10-04-23
NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	07-04-23
NexgenRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	29-11-22
NexgenRx Inc. Announces Dividend on its outstanding common shares, payable on or Before October 10, 2022	23-09-22
NexgenRx Announced Q2 2022 Financial Results	19-08-22
NexgenRx Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	18-08-22
NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	17-05-22
NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	25-03-22
NexgenRx Inc. Announces Dividend, Payable on February 4, 2022	20-01-22
NexgenRx Third-Quarter Profit Falls 15% on Higher Spending	19-11-21
NexgenRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	19-11-21

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen NexgenRx Inc.

Aandelen

NXG

CA65337X1042

Andere talen

Filters